← Leaderboards
Jing Zhao
University Of Pittsburgh At Pittsburgh
$5,052,317
Attributed
$5,052,317
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,052,317 · 3
By mechanism
R01$5,052,317 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joseph A. Carcillo$10,929,314
- Derek C Angus$17,409,826
- Timothy R Billiar$30,423,539
- Sachin Yende$4,689,239
- Beibei Chen$13,818,225
Others in their field
Top investigators on “Scheme”
- Elizabeth A Thom · George Washington University$48,992,457
- Steven M Greenberg · Massachusetts General Hospital$40,565,749
- Robert S Detrick · Woods Hole Oceanographic Institution$38,122,096
- Robert L Woodward · Earthscope Consortium Inc.$38,122,096
- Rebecca Gersnoviez Clifton · George Washington University$37,553,591
- Natalia S Rost · Massachusetts General Hospital$31,323,044
Research focus
SchemePathogenesisPhosphorylationInflammatoryMolecularPlaySepsisFoundationsSeveritiesUbiquitinLipopolysaccharidesInflammatory ResponseRegulationMediatingProteinsNovel TherapeuticsBacteriaMouse ModelMortalityLifeResponseCellsBlood CapillariesPost-Translational Protein Processing
Grant awards (12)
Molecular regulation of immunoproteasome assembly in inflammatory diseases$586,496
R01 · FY2025 · HL · contact PI
Molecular regulation of immunoproteasome assembly in inflammatory diseases$576,618
R01 · FY2024 · HL · contact PI
Molecular regulation of immunoproteasome assembly in inflammatory diseases$621,133
R01 · FY2023 · HL · contact PI
Deubiquitinating and inhibiting Hsp90 by USP40 mitigates lung injury$443,705
R01 · FY2023 · HL · contact PI
Deubiquitinating and inhibiting Hsp90 by USP40 mitigates lung injury$443,705
R01 · FY2022 · HL · contact PI
Deubiquitinating and inhibiting Hsp90 by USP40 mitigates lung injury$412,505
R01 · FY2021 · HL · contact PI
Deubiquitinating and inhibiting Hsp90 by USP40 mitigates lung injury$439,505
R01 · FY2020 · HL · contact PI
Regulation of Histone Acetyltransferase Stability In Sepsis$308,100
R01 · FY2019 · GM · contact PI
Regulation of Histone Acetyltransferase Stability In Sepsis$308,100
R01 · FY2018 · GM · contact PI
Regulation of Histone Acetyltransferase Stability In Sepsis$304,150
R01 · FY2017 · GM · contact PI
Regulation of Histone Acetyltransferase Stability In Sepsis$304,150
R01 · FY2016 · GM · contact PI
Regulation of Histone Acetyltransferase Stability In Sepsis$304,150
R01 · FY2015 · GM · contact PI